Using transgenic mice mutated on ERα subfunctions, we uncovered that both nuclear and membrane ERα signaling are necessary for E2-induced ERα-negative tumor growth while activation of membrane ERα alone by EDC was not sufficient. The gene discussed is ERAL1; the disease is neoplasm.